Synergistic targeting/prodrug strategies for intravesical drug delivery — Lectin-modified PLGA microparticles enhance cytotoxicity of stearoyl gemcitabine by contact-dependent transfer-Reference-Cited by-同舟云学术

Synergistic targeting/prodrug strategies for intravesical drug delivery — Lectin-modified PLGA microparticles enhance cytotoxicity of stearoyl gemcitabine by contact-dependent transfer

Published:2013-07 Issue:1-2 Volume:169 Page:62-72
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Neutsch L.,Wirth E.-M.,Spijker S.,Pichl C.,Kählig H.,Gabor F.,Wirth M.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference50 articles.

1. Potential years of life lost due to urogenital cancer in the United States: trends from 1972 to 2006 based on data from the SEER database;Kamel;J. Urol.,2012

2. Cell biology and physiology of the uroepithelium;Khandelwal;Am. J. Physiol. Renal Physiol.,2009

3. Intravesical drug delivery: challenges, current status, opportunities and novel strategies;GuhaSarkar;J. Control. Release,2010

4. Improving efficacy of intravesical chemotherapy;Gasion;Eur. Urol.,2006

5. Intravesical gemcitabine for superficial bladder cancer: rationale for a new treatment option;Gontero;BJU Int.,2005

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lectin-modified drug delivery systems – Recent applications in the oncology field;International Journal of Pharmaceutics;2024-11

2. Reversal mechanism of multidrug-resistant cancer cells by lectin as chemo-adjuvant and targeted therapy- a systematic review;Phytomedicine;2024-01

3. Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pancreatic cancer treatment;Acta Biomaterialia;2023-09

4. Selective targeting of lectins and their macropinocytosis in urothelial tumours: translation from in vitro to ex vivo;Histochemistry and Cell Biology;2023-08-03

5. Mechanisms and strategies to enhance penetration during intravesical drug therapy for bladder cancer;Journal of Controlled Release;2023-02